A Phase II, Open-Label Trial Evaluating GV1001 in Advanced Hepatocellular Carcinoma.

Clinical trial NCT00444782 · COMPLETED

Trial details

NCT number: NCT00444782
Sponsor: Pharmexa A/S
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Hepatocellular

Start date: 2006-11-01
Primary completion: 2008-04-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.